Monitoring of PPAR alpha protein expression in human tissue by the use of PPAR alpha-specific MAbs

Hybridoma

Volumn 17, Issue 1, 1998, Pages 47-53

  Su, Jui Lan ^a   Simmons, Caroline J ^a   Wisely, Bruce ^a   Ellis, Byron ^a   Winegar, Deborah A ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RECEPTOR PROTEIN; RECEPTOR SUBTYPE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CELL FUSION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SPLEEN CELL;

ANIMALIA;

EID: 0031934477     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1998.17.47     Document Type: Article

References (25)

1. Kliewer S, Forman B, Blumberg B, Ong E, Borgmeyer U, Mangelsdorf D, Umesono K, and Evans R: Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci 1994;91:7355-7359.
2. Elbrecht A, Chen Y, Cullinan C, Hayes N, Leibowitz M, Moller D, and Berger J: Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors γ1 and γ2. Biochem Biophys Res Comm 1996;224:431-437.
3. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, and Wahli W: Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992;68:879-887.
4. Desvergne B, and Wahli W: PPAR: A key nuclear factor in nutrient/gene interactions? In: Bauerle P (ed) Inducible Transcription. Birkhauser, Boston, MA. 1995;1:142-176.
5. Issemann I, and Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferator. Nature 1990;347:645-650.
6. Lemberger T, Desvergne B, and Wahli W: Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology. Ann Rev Cell Dev Biol 1996;12:335-363.
7. Gottlicher M, Widmark E, Li Q, and Gustafsson J: Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci 1992;89:4653-4657.
8. Reddy J, and Lalwani N: Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit Rev Toxicol 1983; 12:1-58.
9. Kliewer S, Sundseth S, Jones S, Brown P, Wisely B, Koble C, Devchand P, Wahli W, Willson T, Lenhard J, and Lehmann J. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors a and γ. Proc Natl Acad Sci 1997;94:4318-1323.
10. Forman B, Chen J, and Evans R: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci 1997;94:4312-4317.
11. Mukherjee R, Jow L, Noonan D, and McDonnell D: Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. 1994;51:157-166.
12. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, and Vidai H: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans. 1997,46:1319-13427.
13. Tontonoz P, Hu E, Graves R, Budavari A, and Spiegelman B: mPPARgamma 2: Tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994;8:1224-1234.
14. Braissant O, Foufelle F, Scotto C, Dauca M, and Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α, β, and -γ in the adult rat. Endocrinology 1996;137:354-366.
15. Cresci S, Wright L, Spratt J, Briggs N, and Kelly D: Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle. Am J Physiol 1996;270:C1413-C1420.
16. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, and Evans R: The nuclear receptor superfamily: The second decade. Cell 1995;83:835-839.
17. Bourguet W, Ruff M, Chambon P, Gronemeyer H, and Moras D: Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 1995;375:377-382.
18. Parker M, and White R: Nuclear receptors spring into action. Nature Struct Biol 1996;3(2):113-115.
19. Miesfeld R: The structure and function of steroid receptor proteins. Crit Rev Biochem Mol Biol 1980;24(2):101-117.
20. Laudet V, and Adelmant G: Lonesome orphans. Curr Biol 1995;5(2):124-127.
21. Su J-L, Becherer JD, Edwards C, Burkhart W, McGeehan G, and Champion BR: Monoclonal antibodies against human collagenase and stromelysin. Hybridoma 1995;14(4):383-390.
22. Kilpatrick KE, Wring SA, Walker DH, Macklin MD, Payne JA, Su J-L, Champion BR, Caterson B, and McIntyre GD: Rapid development of affinity matured monoclonal antibodies using RIMMS. Hybridoma 1997;16(4):387-395.
23. Su J-L, Kilpatrick KE, Champion BR, Morris DC, Lehmann JM, and Kost AT: Fluorescent microtiter screening assay for immunocytochemically reactive antibodies. Bio Techniques 1997;22:320-324.
24. Battifora H: The multitumor (sausage) tissue block: Novel method for immunohistochemical antibody testing. Lab Invest 1986;55(2): 244-248.
25. Fägerstam LG, Frostell-Karlson Persson B, and Rönnberg IJ: Biospecific interaction analysis using surface plasmon resonance detection applied to kinetic, binding site and concentration analysis. Chromatography 1992;597:397-410.